Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 501.47M |
| Enterprise value | 252.02M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 41.97 |
| Price/book (mrq) | 1.88 |
| Enterprise value/revenue | 22.96 |
| Enterprise value/EBITDA | -0.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | -68.52% |
| S&P500 52-week change 3 | -11.22% |
| 52-week high 3 | 6.7400 |
| 52-week low 3 | 1.3800 |
| 50-day moving average 3 | 1.9416 |
| 200-day moving average 3 | 2.3574 |
Share statistics
| Avg vol (3-month) 3 | 5.86M |
| Avg vol (10-day) 3 | 5.37M |
| Shares outstanding 5 | 249.49M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 245.59M |
| % held by insiders 1 | 1.53% |
| % held by institutions 1 | 47.82% |
| Shares short (14 Nov 2022) 4 | 46.15M |
| Short ratio (14 Nov 2022) 4 | 6.75 |
| Short % of float (14 Nov 2022) 4 | 18.78% |
| Short % of shares outstanding (14 Nov 2022) 4 | 18.50% |
| Shares short (prior month 13 Oct 2022) 4 | 45.57M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 05 June 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,889.17% |
Management effectiveness
| Return on assets (ttm) | -42.73% |
| Return on equity (ttm) | -92.27% |
Income statement
| Revenue (ttm) | 10.98M |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | 3,038.20% |
| Gross profit (ttm) | -247.47M |
| EBITDA | -312.91M |
| Net income avi to common (ttm) | -332.3M |
| Diluted EPS (ttm) | -1.5420 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 281.88M |
| Total cash per share (mrq) | 1.13 |
| Total debt (mrq) | 32.43M |
| Total debt/equity (mrq) | 12.16 |
| Current ratio (mrq) | 3.69 |
| Book value per share (mrq) | 1.07 |
Cash flow statement
| Operating cash flow (ttm) | -217.77M |
| Levered free cash flow (ttm) | -97.63M |
© 2022 Yahoo. All rights reserved.
